EverPoint Asset Management’s Array Biopharma ARRY Stock Holding History
Bought
Maintained
Sold
Other funds holding ARRY
EverPoint Asset Management's ARRY Position: Q4 2016 in Review
EverPoint Asset Management opened a new position in Array Biopharma (ARRY) in Q4 2016: 2,500,000 shares worth $22M. The stake represents 0.41% of the portfolio and ranks #57 among its holdings.
167 funds tracked by Wall St. Rank hold ARRY as of Q4 2016.
- EverPoint Asset Management held 2,500,000 shares of Array Biopharma worth $22M as of Q4 2016.
- Array Biopharma was a new EverPoint Asset Management position in Q4 2016.
- Array Biopharma made up 0.41% of EverPoint Asset Management's portfolio in Q4 2016, its #57 holding.
- 167 funds tracked by Wall St. Rank held Array Biopharma as of Q4 2016.
Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.